J. Biol. Chem., Vol. 262, Issue 34, 16376-16385, 12, 1987

Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain

MK Wirtz, RW Glanville, B Steinmann, VH Rao and DW Hollister
Research Department, Shriners Hospital for Crippled Children, Portland, Oregon 97201.

A patient with Ehlers-Danlos syndrome Type VIIB was found to have an interstitial deletion of 18 amino acids in approximately half of the pro-alpha 2(I) chains of Type I procollagen. Analysis of pepsin- solubilized tissue and fibroblast collagen revealed an abnormal additional chain, alpha 2(I)', which migrated in sodium dodecyl sulfate- 5% polyacrylamide gel electrophoresis between the normal alpha 1(I) and alpha 2(I) chains. The apparent ratio of normal alpha 1(I):mutant alpha 2(I)':normal alpha 2(I) was 4:1:1. Procollagen studies and enzyme digestion studies of native mutant collagen suggested defective removal of the amino propeptide. Sieve chromatography of CNBr peptides from purified alpha 2(I)' chains revealed the absence of the normal amino telopeptide fragment CB 1 and the appearance of a larger new peptide of approximately 60 residues (CB X). Compositional and sequencing studies of this peptide identified normal amino propeptide sequences. However, the most carboxyl-terminal tryptic peptide of CB X differed substantially in composition and sequence from the expected and was found to have an interstitial deletion of 18 amino acids corresponding to the N-telopeptide of the pro-alpha 2(I) chain. This deletion removes the normal sites of cleavage of the N-proteinase and also removes a critical cross-linking lysine residue. The 18 amino acids deleted correspond exactly to the residues encoded by exon 6 of the pro-alpha 2(I) collagen gene (COL 1 A2), and, therefore, the protein defect may be due to a genomic deletion, or alternatively, an RNA splicing defect.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Marcellini, N. De Luca, T. Riccioni, A. Ciucci, A. Orecchia, P. M. Lacal, F. Ruffini, M. Pesce, F. Cianfarani, G. Zambruno, et al. Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor Am. J. Pathol., August 1, 2006; 169(2): 643 - 654. [Abstract] [Full Text] [PDF]

				W. A. Cabral, E. Makareeva, A. Colige, A. D. Letocha, J. M. Ty, H. N. Yeowell, G. Pals, S. Leikin, and J. C. Marini Mutations Near Amino End of {alpha}1(I) Collagen Cause Combined Osteogenesis Imperfecta/Ehlers-Danlos Syndrome by Interference with N-propeptide Processing J. Biol. Chem., May 13, 2005; 280(19): 19259 - 19269. [Abstract] [Full Text] [PDF]

				A. Orecchia, P. M. Lacal, C. Schietroma, V. Morea, G. Zambruno, and C. M. Failla Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the {alpha}5{beta}1 integrin J. Cell Sci., September 1, 2003; 116(17): 3479 - 3489. [Abstract] [Full Text] [PDF]

				C. GIUNTA, A. SUPERTI-FURGA, S. SPRANGER, W. G. COLE, and B. STEINMANN Ehlers-Danlos Syndrome Type VII: Clinical Features and Molecular Defects J. Bone Joint Surg. Am., February 1, 1999; 81(2): 225 - 38. [Abstract] [Full Text]